
Enable job alerts via email!
A biotechnology company in Singapore is seeking a Research Scientist in ADC Chemistry to design and assess linker-payload molecules for innovative cancer therapies. Candidates should have a PhD in organic chemistry or a Master's with significant experience, along with expertise in pharmaceutical design and data management. This role offers competitive compensation and a collaborative work environment.
Headquartered in Seattle and Singapore, Callio Therapeutics is focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to transform cancer patient outcomes. Significantly backed by the industry’s top investors, the company is developing next-generation, multi-payload ADCs that feature differentiated payload and linker technologies to maximize therapeutic benefit by enabling targeted delivery of multi agents to tumor cells. Callio Therapeutics is focused on driving its HER2-targeted dual-payload ADC to the clinic, gathering key clinical data, and progressing its pipeline assets.
We are looking for a Research Scientist in ADC Chemistry who will work closely with chemistry and ADC team members as well as other cross-functional and external parties, such as CROs. As a Research Scientist in the Chemistry team, you will support the design, making and assessment of linker-payload molecules in our ADCs.
Education & experience: Minimum qualifications: PhD in organic/medicinal chemistry (preferred), alternatively a Masters degree in organic/medicinal chemistry with a minimum of 6 years, predominantly in industry/CRO setting
Skills: